The legal cannabis industry in North America is worth over $10 billion and employs more than a quarter of a million people, and yet the industry as a whole is decidedly still in its infancy. By comparison, the most recent future projections (from April 2019) expect the global legal cannabis market to be worth over $146 billion USD by the year 2025.
Given the potential for such great value, it is important that the industry has the correct tools to deal with this sort of growth without falling victim to those who may skirt the standards of safety and integrity for personal gain. For this, the cannabis industry may wish to look to the more established pharmaceutical and food and beverage industries for good industry standard practice.
For the first time ever, congressional democrats included a panel at their policy retreat that was focused entirely on cannabis reform.
Last Thursday morning was the panel at the House Democrats’ gathering, with cannabis advocates sharing their point of view on why reform is not only a necessity in this day and age, but also how a new system should be implemented. It was titled “From the War on Drugs to Restorative Justice: Ensuring Racial and Social Equity in the Cannabis Movement,” and was quite busy despite an early, 7:45 am start time.
Overall, conversations weren’t centered on whether to end prohibition or not – which seemed to go without saying as an already accepted conclusion – but rather how to shape the legal industry moving forward. Also discussed was the need to repair past harms caused by the ongoing “war on drugs”. There was a great deal of significance put on the racial injustices of prohibition.
A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also found that patients with cancer are more likely to use prescription opioids than adults without cancer.
Pain is a common symptom of cancer, and many affected patients do not receive adequate pain relief. In light of rapidly evolving marijuana legislation and a growing opioid epidemic, a team led by Jona Hattangadi-Gluth, MD, and Kathryn Ries Tringale, MD, MAS, of the University of California, San Diego, examined trends in the self-disclosed use of marijuana and opioids among patients with cancer.
TORONTO — Medical cannabis users in Alberta can now get their therapeutic pot from Shoppers Drug Mart, with the retail giant opening its second online platform Tuesday in the western province as it pursues the growing market.
The launch follows the January debut of Medical Cannabis by Shoppers Drug Mart in Ontario, where the company says uptake “has been strong.”
As in Ontario, the Alberta platform touts “expert advice and counsel from trusted health-care professionals,” including tips on the purported health properties of various strains, proper dosages and titration techniques.
It’s not uncommon to mistake CBD, or cannabidiol, for marijuana. Some fear it will get them “high,” after all, it does come from the cannabis plant. However, the increasingly popular CBD is the non-psychoactive compound found in cannabis that is known to have potential health benefits. It’s sold in a variety of forms from oils to topicals to candies and capsules, and it’s becoming less of a stranger to the Greeley and Windsor communities.
Co-owner of Gold Care CBD in Greeley, Josh Gutierrez says they go through about 200 to 300 bottles of their 680+ Full Spectrum Hemp Extract every week between selling it in store and to local and New York City-based wholesale clients. One 30 milliliter bottle has 680 milligram of full spectrum hemp oil and runs $45 per bottle.